Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Home Access HIV test reveals more positive cases than national average.

This article was originally published in The Gray Sheet

Executive Summary

HOME ACCESS SURVEY REPORTS LESS THAN 1% HIV-POSITIVE RESPONDENTS in its "HIV Counseling & Testing Report" released by the Hoffman Estates, Illinois-based company Dec. 2. Home Access, which offers the only OTC HIV test, compiled the survey results from anonymous data obtained during pretest counseling. The 0.9% seropositive rate is higher than the Centers for Disease Control & Prevention estimated rate of 0.3% for all HIV tests. The Home Access Survey is designed to complement CDC's biannual published efforts to profile HIV cases and obtain demographic data for those tested at public health sites.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009213

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel